Morphine 2 mg/mL CADD Cassettes Recalled for Sterility Concerns
Medical Center Pharmacy is recalling Morphine 2 mg/mL CADD Cassettes because production processes cannot assure sterility. Patients in Tennessee who received specific prescriptions should contact their healthcare provider.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in a parenteral medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Medical Center Pharmacy, Inc. is recalling Morphine 2 mg/mL Cassettes (100 mL CADD Cassette, Rx only, NDC 00409-1134-03). The recall is due to concerns with production processes that cannot assure the sterility of products intended to be sterile.
The affected product is identified by Lot 03032020@34 with a Beyond-Use Date of 03/17/2020. Distribution was limited to specific prescriptions for patients in Tennessee.
Patients who have received this product should contact their healthcare provider for instructions on what to do next.
The recalled product
- Product
- *Morphine 2 mg/mL Cassette, 100 mL CADD Cassette, Rx only, Medical Center Pharmacy, 2401 N. Ocoee Street, Cleveland, TN 37311, NDC 00409-1134-03.
- Manufacturer
- Medical Center Pharmacy, Inc.
- Category
- Drug — Sterile Injectable
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 03032020@34 BUD: 03/17/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Medical Center Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Medical Center Pharmacy, Inc.
See all →- SevereMedical Center Pharmacy Recalls Mitomycin Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls C-Albumin Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls Vancomycin Opthal Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls Gentamicin Bladder Irrigation Bags
FDA (Drugs) · 2020-04-08
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29